CYRX Earnings & Financial Statements
Cryoport, Inc.
$17.07
+$0.43(+2.58%)
57
Overall
80
Value
54
Tech
39
Quality
Market Cap
$842.80M
Volume
455.02K
52W Range
$7.61 - $18.36
Target Price
$19.67
CYRX earnings and financial statements: Cryoport, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CYRX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $176.18M | $156.77M | $233.25M | $237.28M | $222.61M |
| Cost of revenue | $93.12M | $87.11M | $133.92M | $133.40M | $56.73M |
| Operating income | -$36.81M | -$121.67M | -$115.16M | -$31.90M | -$17.83M |
| EBITDA | $111.39M | -$77.72M | -$63.83M | -$3.61M | -$247.67M |
| Net income | $78.30M | -$114.76M | -$99.59M | -$37.33M | -$275.53M |
| EPS (diluted) | $1.40 | $-2.49 | $-2.21 | $-0.93 | $-6.19 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $764.99M | $703.49M | $957.74M | $1.04B | $1.11B |
| Total liabilities | $262.35M | $301.59M | $468.72M | $482.91M | $471.14M |
| Shareholders’ equity | $502.64M | $401.90M | $489.02M | $555.84M | $641.83M |
| Cash and equivalents | $250.49M | $34.14M | $46.35M | $36.59M | $139.10M |
| Long-term debt | $40.91M | $224.38M | $410.20M | $432.00M | $423.45M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$8.58M | -$16.32M | -$757.0K | -$1.85M | $8.13M |
| Capital expenditure | -$19.50M | -$21.27M | -$44.90M | -$24.20M | -$25.01M |
| Free cash flow | -$28.09M | -$37.59M | -$45.66M | -$26.05M | -$16.88M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CYRX | $17.07 | +2.6% | 455.02K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |